The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.
المخرجات
Research outputs
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
In the present scenario, cancerous tumours are common in humans due to major changes in nearby environments. Skin cancer is a considerable disease detected among people. This cancer is the uncontrolled evolution of atypical skin cells. It occurs when DNA injury to skin cells, or a genetic defect, leads to an increase quickly and establishes malignant tumors. However, in rare instances, many types of skin cancer occur from DNA changes tempted by infrared light affecting skin cells. This disease is a worldwide health problem, so an accurate and appropriate diagnosis is needed for efficient treatment. Current developments in medical technology, like smart recognition and analysis utilizing machine learning (ML) and deep learning (DL) techniques, have transformed the analysis and treatment of these conditions. These approaches will be highly effective for the recognition of skin cancer utilizing biomedical imaging. This study develops a Multi-scale Feature Fusion of Deep Convolutional Neural Networks on Cancerous Tumor Detection and Classification (MFFDCNN-CTDC) model. The main aim of the MFFDCNN-CTDC model is to detect and classify cancerous tumours using biomedical imaging. To eliminate unwanted noise, the MFFDCNN-CTDC method initially utilizes a sobel filter (SF) for the image preprocessing stage. For the segmentation process, Unet3+ is employed, providing precise localization of tumour regions. Next, the MFFDCNN-CTDC model incorporates multi-scale feature fusion by combining ResNet50 and EfficientNet architectures, capitalizing on their complementary strengths in feature extraction from varying depths and scales of the input images. The convolutional autoencoder (CAE) model is utilized for the classification method. Finally, the parameter tuning process is performed through a hybrid fireworks whale optimization algorithm (FWWOA) to enhance the classification performance of the CAE model. A wide range of experiments is performed to authorize the performance of the MFFDCNN-CTDC approach. The experimental validation of the MFFDCNN-CTDC approach exhibited a superior accuracy value of 98.78% and 99.02% over existing techniques under ISIC 2017 and HAM10000 datasets.
skin cancer detectionskin lesion classificationmulti-scale feature fusionconvolutional neural networks
Hematological biomarkers have emerged as powerful tools in diagnosing Acute Heart Failure (AHF). This study introduces a novel diagnostic framework that integrates Explainable Artificial Intelligence (XAI) with Morris Sensitivity Analysis (MSA) to enhance both the interpretability and performance of machine learning models in AHF detection. A dataset consisting of 425 AHF patients and 430 controls was analyzed using eight machine learning models, including XGBoost, Histogram-based Gradient Boosting (histGB), Explainable Boosting Machine (EBM), and Random Forest. Model performance was evaluated through metrics such as AUC, accuracy, precision, recall, and Brier score. Hyperparameters were optimized via Bayesian optimization. Feature importance was assessed using MSA to identify variables with the highest predictive influence. The histGB model achieved the highest performance with an AUC of 87.93%. Both MSA and EBM consistently identified PDW, RDW-CV, NEU, NEU/LY ratio, age, and WBC as top predictive features across multiple models. These hematological markers demonstrated strong potential for early diagnosis and risk stratification in AHF patients. This study presents a clinically relevant, interpretable, and cost-effective diagnostic strategy that combines XAI with MSA for AHF prediction. The framework enhances clinical trust and provides a pathway toward personalized treatment by identifying accessible hematological biomarkers. The integration of explainability into AI models improves their transparency and applicability in real-world clinical settings.
To identify patterns in big medical datasets and use Deep Learning and Machine Learning (ML) to reliably diagnose Cardio Vascular Disease (CVD), researchers are currently delving deeply into these fields. Training on large datasets and producing highly accurate validation results is exceedingly difficult. Furthermore, early and precise diagnosis is necessary due to the increased global prevalence of cardiovascular disease (CVD). However, the increasing complexity of healthcare datasets makes it challenging to detect feature connections and produce precise predictions. To address these issues, the Intelligent Cardiovascular Disease Diagnosis based on Ant Colony Optimisation with Enhanced Deep Learning (ICVD-ACOEDL) model was developed. This model employs feature selection (FS) and hyperparameter optimization to diagnose CVD. Applying a min-max scaler, medical data is first consistently prepared. The key feature that sets ICVD-ACOEDL apart is the use of Ant Colony Optimisation (ACO) to select an optimal feature subset, which in turn helps to upgrade the performance of the ensuring deep learning enhanced neural network (DLENN) classifier. The model reforms the hyperparameters of DLENN for CVD classification using Bayesian optimization. Comprehensive evaluations on benchmark medical datasets show that ICVD-ACOEDL exceeds existing techniques, indicating that it could have a significant impact on CVD diagnosis. The model furnishes a workable way to increase CVD classification efficiency and accuracy in real-world medical situations by incorporating ACO for feature selection, min-max scaling for data pre-processing, and Bayesian optimization for hyperparameter tweaking.